Joseph A. Izatt

Awards & Distinctions

Joseph A. Izatt is the Michael J. Fitzpatrick Distinguished Professor of Engineering in the Edmund T. Pratt, Jr. School of Engineering at Duke University, USA. He received his PhD from Massachusetts Institute of Technology (MIT), where he also completed postdoctoral work. Prior to joining Duke he held positions at University Hospitals of Cleveland, USA and Case Western Reserve University, USA and co-founded Bioptigen.

Izatt is a pioneer in biomedical imaging, a successful entrepreneur and a dedicated teacher. He is also a highly cited author who has published over 200 technical papers and more than 350 contributed conference presentations, delivered 135 invited lectures and presentations, and holds over 75 US patents. He is a Fellow of OSA, the American Institute for Medical and Biological Engineering, the National Academy of Inventors, and SPIE.

He has made fundamental contributions to many coherence-based optical imaging technologies, especially optical coherence tomography (OCT). His accomplishments include playing an integral role in the initial development of retinal OCT, anterior segment OCT, endoscopic OCT, OCT image processing and segmentation, OCT imaging in neonates and children, intrasurgical OCT and OCT-guided robotic ophthalmic surgery. His group also pioneered the combination of OCT and scanning laser ophthalmoscopy in a compact hand-held format, demonstrating the first in vivo imaging of photoreceptors in neonatal infant eyes. Izatt serves as a mentor and educator to a diverse group of students and collaborates with engineers, scientist and clinicians in academia and industry.

An active volunteer, Izatt has served on many OSA councils and committees including the Frontiers in Optics Program Committee, Biomedical Topical Meeting Program Committee, Board of Editors, Publications Council, and Board of Directors. He is the 2020 – 2022 Chair of the Strategic Planning Council.

He received the 2021 Edwin H. Land Medal for foundational contributions to the invention, development, and commercialization of optical coherence-based technologies for in vivo biomedical imaging, and for the education and mentoring of distinguished scientists and engineers.


Document Created: 16 Apr 2021
Last Updated: 3 Nov 2021